Robin Willixhofer
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
High Frequency of Paracentral Acute Middle Maculopathy among symptomatic post-cardiac surgery patients.
Journal: Retina (Philadelphia, Pa.)
Published: July 22, 2026
Beyond the slope: prognostic utility of the VE/VCO2 intercept in chronic heart failure.
Journal: Open heart
Published: June 01, 2026
A novel method to classify exercise response in patients with cardiac amyloidosis - The RoMa classification.
Journal: European journal of preventive cardiology
Published: April 28, 2026
Posture matters: how body position shapes cardiopulmonary response to maximal exercise testing.
Journal: American journal of physiology. Heart and circulatory physiology
Published: April 17, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: April 09, 2026
Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study.
Journal: ESC heart failure
Published: February 01, 2026
Method validation of cardiopulmonary exercise testing: intra- and inter-device comparisons across four metabolic carts.
Journal: European heart journal. Quality of care & clinical outcomes
Published: January 14, 2026
Aficamten Monotherapy for Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: December 17, 2025
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O2-pulse in hypertrophic cardiomyopathy.
Journal: Scientific reports
Published: December 09, 2025
Improved Pulmonary Gas Exchange at Altitude Is Due to Pulmonary Vascular Adaptation to Chronic Hypoxia in Urban Residents.
Journal: High altitude medicine & biology
Published: November 26, 2025
Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging Features.
Journal: Journal of clinical medicine
Published: October 24, 2025
MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake-A Double-Blind, Randomized, and Placebo-Controlled Trial.
Journal: Medical sciences (Basel, Switzerland)
Published: October 06, 2025
Last Updated: 09/26/2026